BTCS INC (BTCS)

US05581M4042 - Common Stock

3.55  -0.22 (-5.84%)

After market: 3.49 -0.06 (-1.69%)

Fundamental Rating

4

Taking everything into account, BTCS scores 4 out of 10 in our fundamental rating. BTCS was compared to 279 industry peers in the Software industry. No worries on liquidiy or solvency for BTCS as it has an excellent financial health rating, but there are worries on the profitability. BTCS has a valuation in line with the averages, but it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

BTCS had positive earnings in the past year.
BTCS had a negative operating cash flow in the past year.
BTCS had negative earnings in 4 of the past 5 years.
BTCS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 46.65%, BTCS belongs to the top of the industry, outperforming 99.64% of the companies in the same industry.
Looking at the Return On Equity, with a value of 47.65%, BTCS belongs to the top of the industry, outperforming 96.42% of the companies in the same industry.
Industry RankSector Rank
ROA 46.65%
ROE 47.65%
ROIC N/A
ROA(3y)-93.72%
ROA(5y)-172.12%
ROE(3y)-104.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BTCS's Profit Margin of 951.30% is amongst the best of the industry. BTCS outperforms 100.00% of its industry peers.
BTCS's Gross Margin of 69.82% is in line compared to the rest of the industry. BTCS outperforms 54.12% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 951.3%
GM 69.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

BTCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BTCS has been increased compared to 1 year ago.
BTCS has more shares outstanding than it did 5 years ago.
BTCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

BTCS has an Altman-Z score of 48.07. This indicates that BTCS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BTCS (48.07) is better than 97.49% of its industry peers.
BTCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 48.07
ROIC/WACCN/A
WACC11.92%

2.3 Liquidity

BTCS has a Current Ratio of 47.45. This indicates that BTCS is financially healthy and has no problem in meeting its short term obligations.
BTCS has a Current ratio of 47.45. This is amongst the best in the industry. BTCS outperforms 99.28% of its industry peers.
A Quick Ratio of 47.45 indicates that BTCS has no problem at all paying its short term obligations.
The Quick ratio of BTCS (47.45) is better than 99.28% of its industry peers.
Industry RankSector Rank
Current Ratio 47.45
Quick Ratio 47.45

2

3. Growth

3.1 Past

BTCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 144.09%, which is quite impressive.
Looking at the last year, BTCS shows a very strong growth in Revenue. The Revenue has grown by 26.62%.
EPS 1Y (TTM)144.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-514.29%
Revenue 1Y (TTM)26.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-61.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

BTCS is valuated cheaply with a Price/Earnings ratio of 6.34.
BTCS's Price/Earnings ratio is rather cheap when compared to the industry. BTCS is cheaper than 96.42% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.20, BTCS is valued rather cheaply.
With a Price/Forward Earnings ratio of 16.57, BTCS is valued correctly.
BTCS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BTCS is cheaper than 83.51% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BTCS to the average of the S&P500 Index (24.00), we can say BTCS is valued slightly cheaper.
Industry RankSector Rank
PE 6.34
Fwd PE 16.57

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BTCS!.
Industry RankSector Rank
Dividend Yield N/A

BTCS INC

NASDAQ:BTCS (11/22/2024, 8:27:17 PM)

After market: 3.49 -0.06 (-1.69%)

3.55

-0.22 (-5.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.59M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.34
Fwd PE 16.57
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 46.65%
ROE 47.65%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 951.3%
GM 69.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 47.45
Quick Ratio 47.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)144.09%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-61.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.62%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y